Tetrahydroindazole inhibitors of bacterial type II topoisomerases. Part 2: SAR development and potency against multidrug-resistant strains-Reference-Cited by-同舟云学术

Tetrahydroindazole inhibitors of bacterial type II topoisomerases. Part 2: SAR development and potency against multidrug-resistant strains

Published:2007-05 Issue:10 Volume:17 Page:2718-2722
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Wiener John J.M.,Gomez Laurent,Venkatesan Hariharan,Santillán Alejandro,Allison Brett D.,Schwarz Kimberly L.,Shinde Shirin,Tang Liu,Hack Michael D.,Morrow Brian J.,Motley S. Timothy,Goldschmidt Raul M.,Shaw Karen Joy,Jones Todd K.,Grice Cheryl A.

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference10 articles.

1. Cloning and primary structure of Staphylococcus aureus DNA topoisomerase IV: a primary target of fluoroquinolones

2. Pyridonecarboxylic acids as antibacterial agents. Part 14. Synthesis and structure-activity relationships of 5-substituted 6,8-difluoroquinolones, including sparfloxacin, a new quinolone antibacterial agent with improved potency

3. Patents on DNA gyrase inhibitors: January 1995 to March 1998

4. The interaction between coumarin drugs and DNA gyrase

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dynamic Profiling and Binding Affinity Prediction of NBTI Antibacterials against DNA Gyrase Enzyme by Multidimensional Machine Learning and Molecular Dynamics Simulations;ACS Omega;2024-04-11

2. Gyrase and Topoisomerase IV: Recycling Old Targets for New Antibacterials to Combat Fluoroquinolone Resistance;ACS Infectious Diseases;2024-04-02

3. Exploring Alternative Pathways to Target Bacterial Type II Topoisomerases Using NBTI Antibacterials: Beyond Halogen-Bonding Interactions;Antibiotics;2023-05-18

4. Amide containing NBTI antibacterials with reduced hERG inhibition, retained antimicrobial activity against gram-positive bacteria and in vivo efficacy;European Journal of Medicinal Chemistry;2023-03

5. Diminishing hERG inhibitory activity of aminopiperidine-naphthyridine linked NBTI antibacterials by structural and physicochemical optimizations;Bioorganic Chemistry;2022-11